Dicerna Pharmaceuticals: Q3 Earnings Insights

Dicerna Pharmaceuticals DRNA reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Dicerna Pharmaceuticals their estimated earnings by 52.17%, reporting an EPS of $-0.22 versus an estimate of $-0.46, which surprised analysts.

Revenue was up $14,079,000 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.94, which was followed by a 6.88% drop in the share price the next day.

Here's a look at Dicerna Pharmaceuticals's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.